Indigo Diabetes is a Ghent based start-up developing a novel glucose sensor technology that was initially developed at Ghent University and IMEC by Indigo’s founders.

Indigo answers the pressing need for accurate and affordable diabetes management by providing novel high-tech solutions for advanced biomarker sensing characterized by the best possible user experience and highest product quality.

Company: Indigo diabetes
Fund: II
Status: active
Team member: Evan Castiglia
Technology: diagnostics
Website: indigomed.com